Aileron Therapeutics, Inc.
ALRN
Revenue
0.00
0.000.00%
3 Months ChangeAssets
104.22M
▼-5.18M▼-4.74%
3 Months ChangeLiabilities
8.99M
▲606.00k▲7.23%
3 Months ChangeFree Cash Flow
-6.56M
▲1.07M▲13.99%
24 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-21
Form 8-K
ID: 0001193125-24-204425
2024-08-14
Form 8-K
ID: 0001193125-24-200739
2024-08-14
Form 10-Q
ID: 0000950170-24-097199
2024-07-26
Form 8-K
ID: 0001193125-24-186279
2024-06-05
Form 8-K
ID: 0001193125-24-154675
2024-05-16
Form 8-K
ID: 0001193125-24-140688
2024-05-15
Form 8-K
ID: 0001193125-24-139510
2024-05-15
Form 10-Q
ID: 0000950170-24-060583
2024-05-01
Form 8-K
ID: 0001193125-24-127657
2024-05-01
Form 8-K
ID: 0001193125-24-126425